Browse All
Displaying 636 - 640 of 1714
Author:Cohen, Jeffrey Hauser, Stephen Zielman, Ronald Das Gupta, Ayan Azmon, Amin Xi, Jing Mavrikis Cox, Gina Robertson, Derrick Wiendl, Heinz Kappos, Ludwig
Session Name:S16: MS Clinical Trials and Therapeutics
Topic:MS and Inflammatory Disease
Program Number:S16.009
Author Institution:Department of Neurology, Mellen MS Center, Neurological Institute, Cleveland Clinic, Cleveland, OH, USA, Cleveland, OH UCSF Weill Institute for Neurosciences, Department of Neurology, University of California - San Francisco, San Francisco, CA, USA, San Francisco, CA Central Texas Neurology Consultants, Round Rock, TX, USA, Round Rock, TX Novartis Pharma B.V., Amsterdam, The Netherlands, Haaksbergweg, Netherlands Novartis Healthcare Pvt. Ltd., Hyderabad, India, Hyderabad, India Novartis Pharma A.G., Basel, Switzerland, Basel, Switzerland China Novartis Institutes for BioMedical Research Co., Ltd, Shanghai, China, Shanghai, China, People's Republic of Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA, East Hanover, NJ Multiple Sclerosis Division, Department of Neurology, University of South Florida, Tampa, FL, USA, Tampa, FL University of Muenster, Muenster, Germany, Muenster, Germany Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB) and MS Center, Departments of Head, Spine and Neuromedicine, Clinical Research, Biomedicine and Biomedical Engineering, University Hospital and University of Basel, Basel, Switzerland, Basel, Switzerland
Author:Cohen, Jeffrey Hauser, Stephen Cross, Anne Winthrop, Kevin Wiendl, Heinz Nicholas, Jacqueline Meuth, Sven Giacomini, Paul Sacca, Francesco Zielman, Ronald Das Gupta, Ayan Hu, Xixi Sullivan, Roseanne DeLasHeras, Virginia Kappos, Ludwig
Session Name:P8: MS Therapeutics 2
Program Number:P8.004
Author Institution:Department of Neurology, Mellen MS Center, Neurological Institute, Cleveland Clinic, Cleveland, OH, USA, Cleveland, OH UCSF Weill Institute for Neurosciences, University of California, San Francisco, CA, USA, San Francisco, CA Washington University School of Medicine, Saint Louis, MO, USA, Clayton, MO Public Health and Preventive Medicine, Division of Infectious Diseases, Oregon Health and Sciences University, Portland, OR, USA, Portland, OR University of Muenster, Muenster, Germany, Muenster, Germany OhioHealth Multiple Sclerosis Center, Columbus, OH, USA, Columbus, OH Department of Neurology, Medical Faculty, Heinrich-Heine-University, Düsseldorf, Germany, Duesseldorf, Germany Department of Neurology and Neurosurgery, Montreal Neurological Institute, McGill University, Montreal, Quebec, Canada, Montreal, QC, Canada NSRO Department, University “Federico II” of Naples, Naples, Italy, Napoli, Italy Novartis Pharma B.V., Amsterdam, The Netherlands, Haaksbergweg, Netherlands Novartis Healthcare Pvt. Ltd., Hyderabad, India, Hyderabad, India Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA, Morristown, NJ Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA, East Hanover, NJ Novartis Pharma AG, Basel, Switzerland, Basel, Switzerland Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB) and MS Center, Departments of Head, Spine and Neuromedicine, Clinical Research, Biomedicine and Biomedical Engineering, University Hospital and University of Basel, Basel, Switzerland, Basel, Switzerland
Author:Nicolau, Stefan Dasgupta, Aneesha Dasari, Surendra Charlesworth, Cristine Johnson, Kenneth Pandey, Akhilesh Doles, Jason Milone, Margherita
Session Name:S7: Outcome Measures and Observational Studies of Neuromuscular Diseases
Topic:Neuromuscular and Clinical Neurophysiology (EMG)
Program Number:S7.001
Author Institution:Nationwide Children's Hospital, Columbus, OH Indiana University, Indianapolis, IN Mayo Clinic, Rochester, MN
Author:Uc, Ergun Anjum, Fahim Dasgupta, Soura Narayanan, Nandakumar
Session Name:P6: Movement Disorders: Parkinson's Disease Non-motor Symptoms 1
Topic:Movement Disorders
Program Number:P6.015
Author Institution:University of Iowa, Iowa City, IA University of California San Francisco, San Francisco, CA
Author:Isaacson, Stuart Ceresoli-Borroni, Gianpiera Espay, Alberto Pahwa, Rajesh Agarwal, Pinky Shill, Holly Hui, Jennifer Dashtipour, Khashayar Lew, Mark Qin, Peibing Nasser, Azmi LeWitt, Peter
Session Name:S32: Movement Disorders: Trials
Program Number:S32.008
Author Institution:Parkinson's Dis & Mov Dis Ctr of Boca Raton, Boca Raton, FL Supernus Pharmaceuticals Inc. , Rockville , MD University of Cincinnati , Cincinnati , OH University of Kansas Medical Center, Kansas City, KS Booth Gardner Parkinson's Center, Evergreen Health, Kirkland, WA Barrow Neurological Institute, University of Arizona, Phoenix, AZ University of Southern California, Los Angeles, CA Department of Neurology, Loma Linda University Health System, Loma Linda , CA Wayne State University School of Medicine, Detroit , MI
